Skip to content
Peptigraph home

SLU-PP-332

ERR agonist (not a peptide). SLU-PP-332 is Not FDA approved · research chemical; research-chemical versions are not the approved drug.

Also called:sluppSLU-PP
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Strongest evidence: Animal evidence, 2 of 4
StatusNot FDA approved · research chemicalWADA status unclearFull legal history

Key facts

How we verify
Class
ERR agonist (not a peptide)
Not a peptide
Also called
slupp, SLU-PP
Vial sizes sold
5 mg
Community-reported sizes
Half-life
Not found
No published half-life found (PubMed search, 2 Oct 2026)
FDA status
Not FDA approved · research chemical
No approved product found
WADA
Unclear
Not named on the 2026 list
Everything on SLU-PP-332

SLU-PP-332 guides

DosageDoses used in published studies, with the source for each.Side effectsWhat labels and studies report, and what is unknown.CalculatorVial, water and dose to syringe units.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Half-lifeWhat is measured, by route, and what is not.For weight lossWhat research says about SLU-PP-332 for weight loss.

Evidence at a glance

Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.

SLU-PP-332: studies by condition
ConditionHuman studiesAnimal studiesStudies we summarisedEvidence grade
Weight lossNot in our ledgerNot in our ledger1Animal evidence, 2 of 4The Journal of pharmacology and experimental therapeutics 2024, PMID 37739806

Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.

Compared with

SLU-PP-332vsMOTS-cERR agonist (not a peptide) next to mitochondrial-derived peptide: evidence, dosing and legal status side by side.PCAC voted 7–5 for 503A (Jul 2026)Read the comparison →SLU-PP-332vs5-Amino-1MQERR agonist (not a peptide) next to nnmt inhibitor (not a peptide): evidence, dosing and legal status side by side.Not FDA approved · research chemicalRead the comparison →

Common stacks

SLU-PP-332 is often sold pre-mixed or combined with other peptides. No controlled study has tested these combinations; the pages below cover the math and what each part has been studied for.

SLU-PP-332 + 5-Amino-1MQSLU-PP-332 + RetatrutideSLU-PP-332 + MOTS-c

Common questions

Is SLU-PP-332 FDA approved?

SLU-PP-332 is Not FDA approved · research chemical. Products sold as research chemicals are not the approved drug and are not checked by the FDA.

Is SLU-PP-332 a peptide?

No. It is a err agonist. It is listed here because people research it alongside peptides.

How much water goes in a 5 mg vial?

That choice only changes the concentration. With 2 mL, the vial is 2.5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.

Sources

  1. 1US search volume and year-over-year trend, Google Keyword Planner export (Jun–Aug 2026 vs 2025)Peptigraph research · 2026peptigraph.com/methodology/Accessed 1 Oct 2026
  2. 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  3. 3United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "SLU-PP-332" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  4. 4A Synthetic ERR Agonist Alleviates Metabolic Syndrome.The Journal of pharmacology and experimental therapeutics · 2024PMID 37739806Accessed 2 Oct 2026
  5. 5PubMed search: "SLU-PP-332"[tiab] (10 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: SLU-PP-332[tiab] OR SLU-PP-915[tiab] OR "ERR agonist"[tiab] AND exercise mimetic[tiab] (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.